The role of nanotechnology in the treatment of viral infections
L Singh, HG Kruger, GEM Maguire… - Therapeutic …, 2017 - journals.sagepub.com
Infectious diseases are the leading cause of mortality worldwide, with viruses in particular
making global impact on healthcare and socioeconomic development. In addition, the rapid …
making global impact on healthcare and socioeconomic development. In addition, the rapid …
On facing the SARS-CoV-2 (COVID-19) with combination of nanomaterials and medicine: possible strategies and first challenges
VS Sivasankarapillai, AM Pillai, A Rahdar, AP Sobha… - Nanomaterials, 2020 - mdpi.com
Global health is facing the most dangerous situation regarding the novel severe acute
respiratory syndrome called coronavirus 2 (SARS-CoV-2), which is widely known as the …
respiratory syndrome called coronavirus 2 (SARS-CoV-2), which is widely known as the …
[HTML][HTML] Artificial intelligence approach fighting COVID-19 with repurposing drugs
YY Ke, TT Peng, TK Yeh, WZ Huang, SE Chang… - Biomedical journal, 2020 - Elsevier
Background The ongoing COVID-19 pandemic has caused more than 193,825 deaths
during the past few months. A quick-to-be-identified cure for the disease will be a therapeutic …
during the past few months. A quick-to-be-identified cure for the disease will be a therapeutic …
Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects
S Cortellino, V Quagliariello, G Delfanti… - Nature …, 2023 - nature.com
Immune checkpoint inhibitors cause side effects ranging from autoimmune endocrine
disorders to severe cardiotoxicity. Periodic Fasting mimicking diet (FMD) cycles are …
disorders to severe cardiotoxicity. Periodic Fasting mimicking diet (FMD) cycles are …
[图书][B] Introduction to Fluorescence Sensing: Volume 2: Target Recognition and Imaging
AP Demchenko - 2023 - books.google.com
Fluorescence is the most popular technique in chemical and biological sensing because of
its ultimate sensitivity, high temporal and spatial resolution and versatility that enables …
its ultimate sensitivity, high temporal and spatial resolution and versatility that enables …
Probiotics and paraprobiotics in viral infection: clinical application and effects on the innate and acquired immune systems
O Kanauchi, A Andoh, S AbuBakar… - Current …, 2018 - ingentaconnect.com
Recently, the risk of viral infection has dramatically increased owing to changes in human
ecology such as global warming and an increased geographical movement of people and …
ecology such as global warming and an increased geographical movement of people and …
Development of effective anti-influenza drugs: congeners and conjugates–a review
JJ Shie, JM Fang - Journal of Biomedical Science, 2019 - Springer
Influenza is a long-standing health problem. For treatment of seasonal flu and possible
pandemic infections, there is a need to develop new anti-influenza drugs that have good …
pandemic infections, there is a need to develop new anti-influenza drugs that have good …
Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review
SS Adam, JR McDuffie, TL Ortel… - Annals of internal …, 2012 - acpjournals.org
Background: New oral anticoagulants (NOACs), including direct thrombin inhibitors (DTIs)
and factor Xa (FXa) inhibitors, are emerging alternatives for prophylaxis and treatment of …
and factor Xa (FXa) inhibitors, are emerging alternatives for prophylaxis and treatment of …
Application of nanotechnology in the COVID-19 pandemic
D Yang - International journal of nanomedicine, 2021 - Taylor & Francis
Abstract COVID-19, caused by SARS-CoV-2 infection, has been prevalent worldwide for
almost a year. In early 2000, there was an outbreak of SARS-CoV, and in early 2010, a …
almost a year. In early 2000, there was an outbreak of SARS-CoV, and in early 2010, a …
An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA
J Zhao, J Wang, X Pang, Z Liu, Q Li, D Yi… - Nature …, 2022 - nature.com
The emergence of new highly pathogenic and drug-resistant influenza strains urges the
development of novel therapeutics for influenza A virus (IAV). Here, we report the discovery …
development of novel therapeutics for influenza A virus (IAV). Here, we report the discovery …